Results 41 to 50 of about 16,624 (211)

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea [PDF]

, 2016
: In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with convalescent plasma derived from patients who have recovered from the disease.
Alexander, N, Andersen, HB, Antierens, A, Arango, D, Bah, EI, Baize, S, Ballo, Y, Bigey, F, Briki, M, Buyze, J, Camara, BS, Chambe, E, Chavarin, P, Claeys, Y, Colebunders, R, COLLABORATORS, Crucitti, T, Custers, A, Cuylaerts, V, De Crop, M, de Lamballerie, X, De Weggheleire, A, Delamou, A, Devillers, M, Ebola-Tx Consortium, Edwards, T, Faye, O, Fransen, K, Gallian, P, Gauthier, M, Gueguen, M, Guillard, A, Haba, N, Horby, PW, Ingelbeen, B, Isola, H, Jacobs, J, Jacquot, C, Jonckheere, S, Konde, K, Lardin, B, Lavedrine, V, Lazaygues, C, Lomas, C, Lynen, L, Magassouba, N, Menten, J, Muyembe, JJ, Olivier, KJ, Raoul, H, Ravinetto, R, Ronse, M, Saez, AM, Sakoba, K, Sall, AA, Semple, MG, Smith, PG, Temmerman, S, Tiberghien, P, Van de Kerckhove, P, Van Den Broecke, S, van Griensven, J, Vermoessen, T   +62 more
core   +1 more source

Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study

São Paulo Medical Journal, 2022
BACKGROUND: Favipiravir is generally used in treating coronavirus disease 2019 (COVID-19) pneumonia in Turkey. OBJECTIVE: To determine the side effects of favipiravir and whether it is a good treatment option.
Figen Öztürk Ergür, Murat Yıldız, Melahat Uzel Şener, Suna Kavurgacı, Ayperi Ozturk   +4 more
doaj   +1 more source

Essentials of Filoviral Load Quantification [PDF]

, 2016
Quantitative measurement of viral load is an important parameter in the management of filovirus disease outbreaks because viral load correlates with severity of disease, survival, and infectivity.
Ariën, KK, Bausch, DG, Cnops, L, Colebunders, R, Formenty, P, Griffiths, A, Hewlett, A, Hill, CE, Honko, AN, Jahrling, PB, Johnson, JC, Kobinger, G, Kraft, CS, Kuhn, JH, Norwood, DA, Palacios, GF, Sabeti, P, Sprecher, A, van Griensven, J   +18 more
core   +1 more source

Favipiravir

Reactions Weekly, 2022
  +7 more sources

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS

Разработка и регистрация лекарственных средств, 2023
Introduction. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus (severe acute respiratory syndrome-related coronavirus 2).
T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely   +7 more
doaj   +1 more source

Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution [PDF]

, 2014
Neuraminidase inhibitors (NAIs) are the only available licensed therapeutics against human H7N9 influenza virus infections. The emergence of NAI-resistant variants of H7N9viruses with an NA R292K mutation poses a therapeutic challenge.
Cai, J, Chen, H, Guan, W, He, J, Hu, Y, Li, J, Liu, L, Liu, Y, Peiris, JSM, Qin, B, Ren, X, Shi, B, Song, Z, Tian, D, Wan, Y, Wang, S, Wang, W, Xu, C, Xu, J, Xu, L, Yang, Y, Yen, H, Yuan, Z, Zhang, W, Zhang, X, Zhang, X, Zhou, W, Zhou, X, Zhu, Z   +28 more
core   +3 more sources

Challenges and recent progress in drug discovery for tropical diseases [PDF]

, 2018
Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries. These diseases predominantly affect the world’s poorest people.
A Guidi, A Hoerauf, AF Francisco, AK Kakkar, AK Njamnshi, AN Cowell, B Amadi, B Baragana, B Blasco, B Wahid, Beatriz Baragaña, CA Fux, CD Huston, CE Barry III, CE Coltart, D Sissoko, DA Lamprecht, DG Brown, DI Stanisic, DM Plouffe, DS Shepard, DT Hoagland, E Bushell, E Chatelain, E Chatelain, E Check Hayden, E Tacconelli, E Torreele, E Wit de, F Josephson, F Macintyre, FJ Sanchez-Valdez, FX Blanc, G Priotto, G-Finder, H Myllymaki, Hotez, I Angulo-Barturen, I Kramnik, I Molina, Ian H. Gilbert, ID Olaru, IPFMA, J Keiser, J Liu, J Whitehorn, JG Kublin, JN Burrows, JP Sarathy, JR Perfect, JS McCarthy, JS McCarthy, K Awadzi, K Basile, KH Mayer, KK Irwin, KL Kotloff, L Conteh, LJ Zhan, LL Silver, M Lee, M Matsumoto, MA Hulverson, Manu De Rycker, MB Jimenez-Diaz, MC Field, MC Pawlowic, MF Fromm, ML Ang, ML Hovlid, MS Love, MY Lim, N Ford, N Gyawali, N Lander, N Woodford, NA Meanwell, NJ White, NJ White, NJ White, NR Mansour, OP Singh, P Buscher, P Horvath, P Steinmann, PG Wyatt, PJ Hotez, R Rajasingham, R Taylor, RT Jacobs, S Baker, S Brooker, S Khare, S Sayasone, SA Mikolajczak, SD Pion, SH Xiao, SM Hammer, Suzanne L. Duce, T Paquet, TF Koning-Ward de, TK Warren, TN Wells, U Klarmann-Schulz, UH Manjunatha, UH Manjunatha, V Boldescu, V Mesu, VK Wong, W Checkley, W Moser, W Moser, W Zheng, Warren, World Health Organization, X Li, Y Debing, Y Wang   +117 more
core   +2 more sources

Analytical Green Star Area for Sample Preparation (AGSA‐Prep) as a Comprehensive and Practice‐Oriented Metric

Analytical Science Advances, Volume 7, Issue 1, June 2026.
ABSTRACT Sample preparation is a critical, yet often environmentally burdensome, step in analytical chemistry. While Green Sample Preparation principles aim to mitigate this impact, existing assessment tools such as AGREEprep offer room for improvement in the assessment process.
Fotouh R. Mansour, Reem H. Obaydo, Marcello Locatelli, Alaa Bedair   +3 more
wiley   +1 more source

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial

Frontiers in Pharmacology, 2021
Background: In addition to supportive therapy, antiviral therapy is an effective treatment for coronavirus disease 2019 (COVID-19).Objective: To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19 patients.Methods ...
Chang Chen, Chang Chen, Yi Zhang, Yi Zhang, Jianying Huang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Bo Chen, Mengxin Lu, Yongwen Luo, Lingao Ju, Jingyi Zhang, Xinghuan Wang, Xinghuan Wang, Xinghuan Wang, Xinghuan Wang   +21 more
doaj   +1 more source

Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey. [PDF]

, 2017
Background Crimean-Congo hemorrhagic fever (CCHF) is acute viral infection and a major emerging infectious diseases threat, affecting a large geographical area. There is no proven antiviral therapy and it has a case fatality rate of 4–30%. The natural
Abuova, Gulzhan Narkenovna, Barut, Sener, Bozkurt, Ilkay, Fletcher, Tom, Leblebicioglu, Hakan, Pshenichnaya, Natalia Yurievna, Sannikova, Irina Viktorovna, Shermetova, Mutabar Bekovna, Zhuravlev, Andrey Sergeevich   +8 more
core   +4 more sources